Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHarvey Nash Group Regulatory News (HVN)

  • There is currently no data for HVN

Director/PDMR Shareholding

29 Oct 2018 07:00

RNS Number : 3880F
Harvey Nash Group PLC
29 October 2018
 

29 October 2018

 

Director/PDMR Shareholding

Harvey Nash Group Plc

("the Company")

Notification of Transaction by Directors

In accordance with DTR 3.1 and Article 19 of The Market Abuse Regulation, the Company was advised on 26 October 2018 that Albert Ellis, Simon Wassall and Mark Garratt had acquired ordinary shares in London on 26 October 2018 at a price of £0.05 per ordinary share as a result of the exercise of options granted under the Company's Performance Share Plan which became exercisable as a result of the offer by The Power of Talent Ltd being declared wholly unconditional on 26 October 2018:

Director

Number of shares purchased

Price per share

Resulting holding

Albert Ellis

1,385,499

£0.05

2,267,084*

Simon Wassall

930,215

£0.05

1,259,331

Mark Garratt

381,229

£0.05

416,787

*Includes 658,923 ordinary shares held by family members.

The notification below provides further detail.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them. 

1

Details of the person discharging managerial responsibility

a)

Name

Albert Ellis

2

Reason for the notification

a)

Position/status

Chief Executive

 

b)

Initial notification/amendment

Initial notification

 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Full name of the entity

Harvey Nash Group plc

b)

Legal Entity Identifier Code

2138004ULQUX3DQSCV07

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary shares of £0.05 each

ISIN: GB0006573546

c)

Nature of the transaction

Acquisition through Company Performance Share Plan.

e)

Price(s) and Volume(s)

Exercise:

Price(s) per share

Volume(s)

Aggregate Price

£0.05

1,385,499

£69,274.95

 

 

 

g)

Date of transaction

26 October 2018

h)

Place of transaction

London Stock Exchange XLON

 

1

Details of the person discharging managerial responsibility

a)

Name

Simon Wassall

2

Reason for the notification

a)

Position/status

European Managing Director

 

b)

Initial notification/amendment

Initial notification

 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Full name of the entity

Harvey Nash Group plc

b)

Legal Entity Identifier Code

2138004ULQUX3DQSCV07

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary shares of £0.05 each

ISIN: GB0006573546

c)

Nature of the transaction

Acquisition through Company Performance Share Plan.

e)

Price(s) and Volume(s)

Exercise:

Price(s) per share

Volume(s)

Aggregate Price

£0.05

930,215

£46,510.75

 

 

 

g)

Date of transaction

26 October 2018

h)

Place of transaction

London Stock Exchange XLON

 

1

Details of the person discharging managerial responsibility

a)

Name

Mark Garratt

2

Reason for the notification

a)

Position/status

Group Finance Director

 

b)

Initial notification/amendment

Initial notification

 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Full name of the entity

Harvey Nash Group plc

b)

Legal Entity Identifier Code

2138004ULQUX3DQSCV07

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary shares of £0.05 each

ISIN: GB0006573546

c)

Nature of the transaction

Acquisition through Company Performance Share Plan.

e)

Price(s) and Volume(s)

Exercise:

Price(s) per share

Volume(s)

Aggregate Price

£0.05

381,229

£19,061.45

 

 

 

g)

Date of transaction

26 October 2018

h)

Place of transaction

London Stock Exchange XLON

 

Contact:

Mark Garratt, Group Finance Director - 020 7333 0033

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHFEUFMMFASEES
Date   Source Headline
6th Mar 20073:23 pmRNSInterest in Shares
27th Feb 20071:38 pmRNSHolding(s) in Company
26th Feb 200712:12 pmRNSHolding(s) in Company
21st Feb 20079:05 amRNSShareholding
26th Jan 200712:25 pmRNSAdditional Listing
26th Jan 20077:01 amRNSTrading Statement
22nd Dec 200611:05 amRNSTotal Voting Rights
13th Dec 200612:24 pmRNSBlocklisting Interim Review
27th Nov 20067:00 amRNSTransfer of Shares
10th Oct 20067:01 amRNSInterim Results
7th Sep 20067:01 amRNSOpening of Scottish office
8th Aug 20067:01 amRNSTrading Statement
31st Jul 20061:01 pmRNSShare Premium Account
29th Jun 20065:25 pmRNSHolding(s) in Company
29th Jun 20061:48 pmRNSResult of AGM
29th Jun 20067:01 amRNSAGM Statement
22nd Jun 200610:29 amRNSHolding(s) in Company
13th Jun 20069:56 amRNSBlocklisting Interim Review
2nd Jun 20067:00 amRNSAnnual Report and Accounts
26th May 20067:00 amRNSDirector/PDMR Shareholding
26th May 20067:00 amRNSDirector/PDMR Shareholding
26th May 20067:00 amRNSDirector/PDMR Shareholding
26th May 20067:00 amRNSAdditional Listing
23rd May 20063:33 pmRNSAnnual Information Update
5th May 20068:00 amRNSDisposal
24th Apr 20067:01 amRNSFinal Results
19th Apr 20069:02 amRNSHolding(s) in Company
19th Apr 20067:00 amRNSAdditional Listing
13th Apr 200611:32 amRNSBlock Listing
23rd Mar 200610:31 amRNSHolding(s) in Company
21st Mar 20067:00 amRNSHolding(s) in Company
13th Mar 20062:53 pmRNSHolding(s) in Company
23rd Feb 20069:00 amRNSAdditional Listing
22nd Feb 20067:01 amRNSPre-close trading statement
11th Jan 20067:00 amRNSShareholding
22nd Dec 200511:10 amRNSHolding(s) in Company
22nd Dec 200511:07 amRNSHolding(s) in Company
16th Dec 20052:37 pmRNSHolding(s) in Company
13th Dec 20053:47 pmRNSBlocklisting Interim Review
10th Nov 20056:25 pmRNSDoc re. Interim Report
31st Oct 20053:34 pmRNSHolding(s) in Company
17th Oct 20057:00 amRNSInterim Results
17th Oct 20057:00 amRNSBoard Appointments
16th Aug 20055:51 pmRNSPre-close trading statement
16th Aug 20057:00 amRNSPre-close trading statement
1st Aug 20057:00 amRNSAppointment of Broker
18th Jul 20051:51 pmRNSDirector Shareholding
11th Jul 200512:55 pmRNSHolding(s) in Company
30th Jun 20057:15 amRNSExercise of call option
30th Jun 20057:00 amRNSAGM Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.